| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 03/01/2012 | 14:00 | Marketwired | Poniard Pharmaceuticals Common Stock to Be Delisted From Nasdaq Stock Market, Intention to List on OTC Bulletin Board | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 23/12/2011 | 21:37 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 21/11/2011 | 19:15 | Marketwired | Poniard Pharmaceuticals Announces Shareholders Approve Merger With ALLOZYNE | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 21/11/2011 | 15:00 | Marketwired | Steps in the Right Direction - Featured Research on Poniard Pharmaceuticals, Inc. and Gilead Sciences, Inc. | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 18/11/2011 | 19:00 | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 18/11/2011 | 14:30 | Marketwired | Poniard Pharmaceuticals Announces Licensing Agreement for Focal Adhesion Kinase Technology | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 09/11/2011 | 14:30 | Marketwired | ISS Proxy Advisory Services Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse St... | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 07/11/2011 | 14:30 | Marketwired | Glass Lewis Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock Split | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 04/11/2011 | 11:10 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 28/10/2011 | 22:01 | Marketwired | Poniard Pharmaceuticals Reports Third Quarter 2011 Financial Results | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 28/10/2011 | 19:59 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 28/10/2011 | 14:30 | Marketwired | Egan-Jones Recommends Poniard Shareholders Vote "FOR" Poniard's Proposed Merger With ALLOZYNE and Reverse Stock Split | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 21/10/2011 | 20:00 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 11/10/2011 | 15:10 | Dow Jones News | Registration Effectiveness Orders Issued By The SEC | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 11/10/2011 | 12:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 07/10/2011 | 23:43 | Marketwired | Poniard Pharmaceuticals Announces Effectiveness of Form S-4 Registration Statement for the Proposed Merger with ALLOZYNE | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 07/10/2011 | 23:27 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 07/10/2011 | 19:22 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 06/10/2011 | 18:33 | Edgar (US Regulatory) | Registration Statement for securities to be issued in business combination transactions (S-4/A) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 06/09/2011 | 14:39 | Marketwired | Poniard Pharmaceuticals Receives Favorable NASDAQ Decision for Continued Listing of Company Shares | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 12/08/2011 | 22:01 | Marketwired | Poniard Pharmaceuticals Reports Second Quarter 2011 Financial Results | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 25/07/2011 | 23:38 | Marketwired | Poniard Pharmaceuticals Announces Filing of Form S-4 Registration Statement Related to Proposed Merger With ALLOZYNE | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 25/07/2011 | 23:22 | Edgar (US Regulatory) | Securities Registration: Business Combination (S-4) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 11/07/2011 | 17:49 | Marketwired | Poniard Pharmaceuticals Adjourns Reconvened Annual Meeting of Shareholders to Solicit Additional Proxies for Important Reverse S | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 08/07/2011 | 01:09 | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Poniard Pharmaceuticals, Inc. | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 05/07/2011 | 14:30 | Marketwired | Poniard Pharmaceuticals Announces Intention to Adjourn Annual Meeting of Shareholders to Solicit Additional Proxies for Importan | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 05/07/2011 | 12:03 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 23/06/2011 | 01:06 | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Poniard Pharmaceuticals, Inc. | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 22/06/2011 | 22:26 | Marketwired | Poniard Pharmaceuticals and ALLOZYNE Sign Definitive Merger Agreement | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |
| 09/06/2011 | 19:31 | Marketwired | Poniard Pharmaceuticals Adjourns Annual Meeting of Shareholders | NASDAQ:PARD | Poniard Pharmaceuticals, Inc. (MM) |